Analysis and Commentary STEVEN GROSSMAN 5/17/19 Analysis and Commentary STEVEN GROSSMAN 5/17/19 Regular Order Appropriations: Enshrined in Law, but Not in Practice Read More Advocacy at a Glance STEVEN GROSSMAN 5/17/19 Advocacy at a Glance STEVEN GROSSMAN 5/17/19 Mixed Signals on Whether the White House Wants a Budget Deal Read More Analysis and Commentary STEVEN GROSSMAN 5/10/19 Analysis and Commentary STEVEN GROSSMAN 5/10/19 Potential Promise ... But Storm Clouds on Horizon Read More Advocacy at a Glance STEVEN GROSSMAN 5/10/19 Advocacy at a Glance STEVEN GROSSMAN 5/10/19 No Budget Agreement: House Moves Forward, Senate Waits Read More Analysis and Commentary STEVEN GROSSMAN 5/3/19 Analysis and Commentary STEVEN GROSSMAN 5/3/19 Federal Budgeting: A Brief Refresher Course Read More Advocacy at a Glance STEVEN GROSSMAN 5/3/19 Advocacy at a Glance STEVEN GROSSMAN 5/3/19 House Appropriations Subcommittees Begin FY 20 Bill Approvals Read More Analysis and Commentary STEVEN GROSSMAN 4/19/19 Analysis and Commentary STEVEN GROSSMAN 4/19/19 Gains and Gaps in Knowledge about Shutdown Processes Read More Advocacy at a Glance STEVEN GROSSMAN 4/19/19 Advocacy at a Glance STEVEN GROSSMAN 4/19/19 Budget and Appropriations: Progress But No Clear Path Forward Read More Analysis and Commentary STEVEN GROSSMAN 4/12/19 Analysis and Commentary STEVEN GROSSMAN 4/12/19 FY 20: The "Ask"; the Possible; and the Realities Read More Advocacy at a Glance STEVEN GROSSMAN 4/12/19 Advocacy at a Glance STEVEN GROSSMAN 4/12/19 Hearings on FDA’s Budget are Completed. What Next? Read More Analysis and Commentary STEVEN GROSSMAN 3/29/19 Analysis and Commentary STEVEN GROSSMAN 3/29/19 What Chairman Hoeven Said, and Why Read More Advocacy at a Glance STEVEN GROSSMAN 3/29/19 Advocacy at a Glance STEVEN GROSSMAN 3/29/19 Commissioner Gottlieb Testifies Before the Senate Ag/FDA Appropriations Subcommittee Read More STEVEN GROSSMAN 3/22/19 STEVEN GROSSMAN 3/22/19 Gottlieb and McClellan: A "Fireside Chat" Read More Analysis and Commentary STEVEN GROSSMAN 3/22/19 Analysis and Commentary STEVEN GROSSMAN 3/22/19 Sorting Out the Details of the President's FY 20 Request Read More Advocacy at a Glance STEVEN GROSSMAN 3/22/19 Advocacy at a Glance STEVEN GROSSMAN 3/22/19 Alliance Hill Day Tops 60 Meetings Read More Analysis and Commentary STEVEN GROSSMAN 3/16/19 Analysis and Commentary STEVEN GROSSMAN 3/16/19 Reading the Tea Leaves Prior to the CJ Read More Advocacy at a Glance STEVEN GROSSMAN 3/16/19 Advocacy at a Glance STEVEN GROSSMAN 3/16/19 Hill Day Coming at the Perfect Time. Now We Need You to Participate Read More STEVEN GROSSMAN 3/12/19 STEVEN GROSSMAN 3/12/19 Sharpless Appointed Acting Commissioner of FDA Read More STEVEN GROSSMAN 3/11/19 STEVEN GROSSMAN 3/11/19 Alliance Issues Initial Statement Read More Analysis and Commentary STEVEN GROSSMAN 3/8/19 Analysis and Commentary STEVEN GROSSMAN 3/8/19 FY 20 President's Budget Request; Spin and Reality Read More Newer Posts Older Posts
Analysis and Commentary STEVEN GROSSMAN 5/17/19 Analysis and Commentary STEVEN GROSSMAN 5/17/19 Regular Order Appropriations: Enshrined in Law, but Not in Practice Read More
Advocacy at a Glance STEVEN GROSSMAN 5/17/19 Advocacy at a Glance STEVEN GROSSMAN 5/17/19 Mixed Signals on Whether the White House Wants a Budget Deal Read More
Analysis and Commentary STEVEN GROSSMAN 5/10/19 Analysis and Commentary STEVEN GROSSMAN 5/10/19 Potential Promise ... But Storm Clouds on Horizon Read More
Advocacy at a Glance STEVEN GROSSMAN 5/10/19 Advocacy at a Glance STEVEN GROSSMAN 5/10/19 No Budget Agreement: House Moves Forward, Senate Waits Read More
Analysis and Commentary STEVEN GROSSMAN 5/3/19 Analysis and Commentary STEVEN GROSSMAN 5/3/19 Federal Budgeting: A Brief Refresher Course Read More
Advocacy at a Glance STEVEN GROSSMAN 5/3/19 Advocacy at a Glance STEVEN GROSSMAN 5/3/19 House Appropriations Subcommittees Begin FY 20 Bill Approvals Read More
Analysis and Commentary STEVEN GROSSMAN 4/19/19 Analysis and Commentary STEVEN GROSSMAN 4/19/19 Gains and Gaps in Knowledge about Shutdown Processes Read More
Advocacy at a Glance STEVEN GROSSMAN 4/19/19 Advocacy at a Glance STEVEN GROSSMAN 4/19/19 Budget and Appropriations: Progress But No Clear Path Forward Read More
Analysis and Commentary STEVEN GROSSMAN 4/12/19 Analysis and Commentary STEVEN GROSSMAN 4/12/19 FY 20: The "Ask"; the Possible; and the Realities Read More
Advocacy at a Glance STEVEN GROSSMAN 4/12/19 Advocacy at a Glance STEVEN GROSSMAN 4/12/19 Hearings on FDA’s Budget are Completed. What Next? Read More
Analysis and Commentary STEVEN GROSSMAN 3/29/19 Analysis and Commentary STEVEN GROSSMAN 3/29/19 What Chairman Hoeven Said, and Why Read More
Advocacy at a Glance STEVEN GROSSMAN 3/29/19 Advocacy at a Glance STEVEN GROSSMAN 3/29/19 Commissioner Gottlieb Testifies Before the Senate Ag/FDA Appropriations Subcommittee Read More
Analysis and Commentary STEVEN GROSSMAN 3/22/19 Analysis and Commentary STEVEN GROSSMAN 3/22/19 Sorting Out the Details of the President's FY 20 Request Read More
Advocacy at a Glance STEVEN GROSSMAN 3/22/19 Advocacy at a Glance STEVEN GROSSMAN 3/22/19 Alliance Hill Day Tops 60 Meetings Read More
Analysis and Commentary STEVEN GROSSMAN 3/16/19 Analysis and Commentary STEVEN GROSSMAN 3/16/19 Reading the Tea Leaves Prior to the CJ Read More
Advocacy at a Glance STEVEN GROSSMAN 3/16/19 Advocacy at a Glance STEVEN GROSSMAN 3/16/19 Hill Day Coming at the Perfect Time. Now We Need You to Participate Read More
STEVEN GROSSMAN 3/12/19 STEVEN GROSSMAN 3/12/19 Sharpless Appointed Acting Commissioner of FDA Read More
Analysis and Commentary STEVEN GROSSMAN 3/8/19 Analysis and Commentary STEVEN GROSSMAN 3/8/19 FY 20 President's Budget Request; Spin and Reality Read More
